Clinical Trials for Overexpression FGFR2b

Find clinical trials for overexpression fgfr2b. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Open-label Non-randomized Multicentric Phase 2 Study Evaluating the Combination of Bemarituzumab + FLOT Chemotherapy in Perioperative Setting for Resectable Stage cT2-T4a or N+ Gastric and GEJ Adenocarcinoma Overexpressing FGFR2b

NCT ID: NCT06967987

This clinical trial is investigating a new treatment approach for patients with stomach cancer or gastro-oesophageal junction (GEJ) cancer that is operable and has specific characteristics, such as...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Dijon, , France, Poitiers, , France +10 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions